06.26.24 -- Navigate The Current Outsourcing Landscape With Ease And Connect With Top CDMOs

Explore our range of offerings, including our high-speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA.

INCOG has been designed and built to deliver better CDMO services in the injectable drug product space. Gain an overview and update of our expanding capabilities with an inside look at our facility.

Senior Business Development Manager, Christine Rodi, highlights our overall sterile injectable drug substance capabilities, with a focus on our ability to help meet your complex sterile injectable needs.

Alcami offers sterile drug product fill finish services including formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial manufacturing.

Learn more about our integrated offerings in mammalian drug substance and drug product. Our drug product (Fill & Finish) services cover vials (LivI, Lyo), syringes (PFS), Cartrdiges and Auto Injectors.

We leverage decades of scientific expertise, operational excellence, and state-of-the-art facilities to provide one of the most reliable manufacturing options for fill-finish processes.

Review our global sterile fill-finish and lyophilization capabilities, capacities, and how strategic investments allow us to meet the growing need for expert sterile development and manufacturing.

Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. Hear about how we can support manufacturing programs from clinical through commercial.

We are a sustainable partner in the commercial manufacturing of your liquid products. To advance therapeutic and prophylactic therapies, we have set up state-of-the-art high-speed filling capacities.

Our facility offers ~2,000 sq. ft. of process and analytical development labs and ~8,600 sq. ft. of cGMP-compliant cleanroom manufacturing space for mammalian and microbial programs.

Learn more about our global Biologics network, track record, and capabilities. Plus, take a detailed look at our Copenhagen site and how we balance flexibility with scale to meet the demands of clients.

EirGenix has immediate capacity availability up to 12 x 2,000 L SUBs for mammalian cells and up to 150 L scale for microbial. The microbial capacity will increase to 350L and 1,000L by 2025.

Review our Analytical, Product and Process Development, and Manufacturing capabilities along with the knowledge required to demonstrate product and process understanding.

We provide license-free use of our proprietary CHO-K1 cell lines (wild type, GS-/-, and FUT8-/-) and offer cGMP suites, which are equipped with single-use and traditional stainless steel bioreactors.

Review our installations in upstream development, downstream development, and fill & finish. Our EU-GMP certified facility is staffed by a team of 250 professionals and focuses on providing CDMO services.

Discover how our development and platform-based manufacturing solutions can create an unobstructed path to market for your large molecule pipeline in a dynamic regulatory environment.

The therapeutic promise of biologicals has fundamentally changed health care. Samsung Biologics is committed to helping drug developers bring these promising new therapeutics to patients.